Graft versus host disease in skin and Haematocrit abnormal

Summary:

Haematocrit abnormal is reported only by a few people with Graft versus host disease in skin.

The study analyzes which people have Haematocrit abnormal with Graft versus host disease in skin. It is created by eHealthMe based on 1 person who has Haematocrit abnormal and Graft versus host disease in skin from the Food and Drug Administration (FDA), and is updated regularly.

What is Graft versus host disease in skin?

Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin) is found to be associated with 160 drugs and 252 conditions by eHealthMe. Check the latest studies of Graft versus host disease in skin.

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 280 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

On Jul, 21, 2026

1 person who has Graft Versus Host Disease In Skin and Haematocrit Abnormal is studied.

Would you have Haematocrit abnormal when you have Graft versus host disease in skin?

Common co-existing conditions for these people *:

Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 100.00%

Common drugs taken by these people *:

Common symptoms for these people *:

White Blood Cell Count Abnormal: 1 person, 100.00%
Weight Decreased: 1 person, 100.00%
Red Blood Cell Count Abnormal: 1 person, 100.00%
Platelet Count Abnormal: 1 person, 100.00%
Oedema Peripheral (superficial swelling): 1 person, 100.00%
Hepatic Failure (liver failure): 1 person, 100.00%
Hepatic Enzyme Abnormal: 1 person, 100.00%
Haemoglobin Abnormal: 1 person, 100.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 100.00%
Full Blood Count Decreased: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit abnormal and Graft versus host disease in skin, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.